ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,066.00
-0.07%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
66,961.44
-0.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Ampio Pharmaceuticals Inc (AMPE)

  7. Ampio Pharmaceuticals Inc (AMPE) News

AMPE

Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AMPE
DateTimeSourceHeadlineSymbolCompany
04/03/20242:33PMPR Newswire (US)Ampio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationAMEX:AMPEAmpio Pharmaceuticals Inc
03/25/20245:00PMPR Newswire (US)Ampio Announces Voluntary Delisting and SEC DeregistrationAMEX:AMPEAmpio Pharmaceuticals Inc
03/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
02/28/20243:49PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
02/28/20243:48PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
02/28/20243:47PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
02/28/20243:46PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:AMPEAmpio Pharmaceuticals Inc
02/28/20243:45PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestAMEX:AMPEAmpio Pharmaceuticals Inc
02/15/20249:31AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
02/14/20245:45PMPR Newswire (US)Ampio Provides Update on Results from Pre-IND Enabling StudiesAMEX:AMPEAmpio Pharmaceuticals Inc
01/25/20244:31PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
01/25/20244:18PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
01/24/20245:16PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
01/11/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
01/11/20244:15PMPR Newswire (US)Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal ActionsAMEX:AMPEAmpio Pharmaceuticals Inc
12/21/20234:25PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
11/14/20234:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AMPEAmpio Pharmaceuticals Inc
11/02/20239:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
10/31/20239:00AMPR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
10/27/20232:10PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
10/06/20232:56PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
10/05/20234:30PMPR Newswire (US)Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201AMEX:AMPEAmpio Pharmaceuticals Inc
10/04/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
10/02/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
09/26/20239:15AMPR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
09/22/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
09/18/20234:30PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
08/31/20234:19PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
08/31/20236:30AMPR Newswire (US)Ampio Pharmaceuticals Announces Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
08/15/20234:56PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AMPEAmpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:AMPE

Your Recent History

LSE
62QE
Gros Uk Fin
NASDAQ
NOACW
Natural Order Acquisition
BIT
O8JPV1
Morgan Stanley BV
BIT
P14P92
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved